Rigel Pharmaceuticals to price a public offering of its common shares

Company to sell stock through Jefferies & Co., J.P. Morgan Securities

By Devika Patel

Knoxville, Tenn., May 25 - Rigel Pharmaceuticals, Inc. said it will conduct a public sale of common stock.

Jefferies & Co., Inc. and J.P. Morgan Securities LLC will be the joint bookrunning managers and Piper Jaffray & Co. will be the co-manager.

Rigel is a South San Francisco, Calif., drug development company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.